HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applications engineered to automate the processing of samples and characterize a variety of molecular targets. Among their portfolio of molecular profiling panels are offerings like the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay EU, HTG EdgeSeq Oncology Biomarker Panel, HTG immune response panel, and the HTG mouse mRNA tumor response panel.